# Lung Health Study (LHS) I and III

> **NCT00000568** · PHASE3 · COMPLETED · sponsor: **National Heart, Lung, and Blood Institute (NHLBI)**

## Conditions studied

- Lung Diseases
- Lung Diseases, Obstructive
- Chronic Obstructive Pulmonary Disease

## Interventions

- **BEHAVIORAL:** smoking cessation
- **DRUG:** ipratropium

## Key facts

- **NCT ID:** NCT00000568
- **Lead sponsor:** National Heart, Lung, and Blood Institute (NHLBI)
- **Sponsor class:** NIH
- **Phase:** PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 1984-09
- **Primary completion:** —
- **Final completion:** 2005-01
- **Target enrollment:** — (—)
- **Last updated:** 2016-04-14


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00000568

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00000568, "Lung Health Study (LHS) I and III". Retrieved via AI Analytics 2026-05-26 from https://api.ai-analytics.org/clinical/NCT00000568. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*